The company has production facilities that have passed the national GMP certification, and the production capacity of Chinese and western medicine preparations reaches 65.438+0.5 billion tablets. The company has purchased 65,438+000,000 square meters (65,438+050 mu) of land in Yanjiao Economic and Technological Development Zone adjacent to Beijing, and is planning an industrial park that meets international standards.
The company cooperates with Tsinghua University and other parties. As one of the five largest shareholders, Shenzhen Chipscreen Biotechnology Co., Ltd. was established, and plans to develop and produce system products with biochip as the core combination technology for drug screening beyond Qualcomm.
The company has a high-quality staff with an average age of 29. The proportion of senior and intermediate professional and technical personnel is 64.28%, and Cody talent echelon with strong scientific research and management ability has been initially formed.
The company has established its own pharmaceutical distribution company, with offices and agents in 28 provinces and cities across the country, and also opened a retail chain pharmacy-Cody Pharmacy, and its sales system is improving day by day. At the same time, we will introduce scientific management quality standards, pass the acceptance of national GSP standards, actively expand the international market and carry out international trade.
After years of careful cultivation, the company has initially formed its own corporate culture system. Cody people adhere to the corporate philosophy of "dedicating themselves to science and benefiting society" and the corporate spirit of "understanding, cohesion, science and efficiency", and form the corporate style of "democratizing decision-making and militarizing implementation". It embodies the spirit of "thinking, morality, motivation and discipline" of all employees.
The company is actively preparing for the listing of Hi-tech Growth Enterprise Market, perfecting the modern enterprise system, accelerating the industrialization process of traditional Chinese medicine pharmaceutical equipment manufacturing and technology, relying on strong technological advantages, increasing the development of new drugs and biotechnology products, constantly cultivating new economic growth points, and building Cody into a modern high-tech international enterprise group.
The company has set up more than 20 offices all over the country, trained a professional clinical promotion team of hundreds of people, and formed a mature hospital sales network centered on provincial capitals and extending to prefectural and county markets. Products have covered more than 2,000 large and medium-sized hospitals and more than 654.38 million drug retail terminals.
In August 2009, the company's flagship product, Longbishu Capsule, entered the first batch of national essential drugs list (the part equipped and used by primary medical and health institutions) (2009 edition). Longbishu capsule successfully entered the list, which means that Cody people's hard work and hard work for more than ten years have finally been recognized by the majority of patients and medical experts, which indicates that Cody has entered a new stage and entered a new era under the conditions of the new national medical reform policy!
The company adheres to the professional and dedicated business philosophy, and wins the unanimous praise of customers with the honest business philosophy and the spirit of seeking truth and being pragmatic. The company will focus on the research and development, production and sales of men's health products, adhering to the corporate philosophy of "Cody is everyone, everyone is the owner of the enterprise" and unswervingly take the road of innovation and development. Market-oriented, constantly enhance the core competitive advantage of enterprises, lead modern Chinese medicine with rich professional experience, first-class product quality and excellent marketing strategy, and promote the health industry to achieve new take-off.